Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2023 Mar 1.

Published in final edited form as: Ann Thorac Surg. 2022 Jan 7;113(3):722–737. doi: 10.1016/j.athoracsur.2021.12.011

Figure 6: — Reasons for Readmission after LVAD and Patient Survival after Readmissions Occurring in the first 6-months. A) The major reasons for readmission after continuous-flow left ventricular assist device implantation. B) All continuous-flow left ventricular assist device patients who survived to 6-months (n=21,013) are stratified by the number of hospital readmissions occurring during the first 6-months after implant. Kaplan-Meier estimated survival is then provided based on number of readmissions during the initial 6-month period. Shaded areas indicate 70% confidence limits, p (log-rank) = <0.0001, Event: Death (censored at transplant or cessation of support).

Figure 6: — Reasons for Readmission after LVAD and Patient Survival after Readmissions Occurring in the first 6-months. A) The major reasons for readmission after continuous-flow left ventricular assist device implantation. B) All continuous-flow left ventricular assist device patients who survived to 6-months (n=21,013) are stratified by the number of hospital readmissions occurring during the first 6-months after implant. Kaplan-Meier estimated survival is then provided based on number of readmissions during the initial 6-month period. Shaded areas indicate 70% confidence limits, p (log-rank) = <0.0001, Event: Death (censored at transplant or cessation of support).